CDC Logo Tuberculosis Information CD-ROM   Image of people
     
jump over main navigation bar to content area
Home
TB Guidelines
Surveillance Reports
Slide Sets
TB-Related MMWRs and Reports
Education/Training Materials
Newsletters
Ordering Information
Help

 

U.S. Department of Health and Human Services

  

TB Notes Newsletter

No. 3, 2005

NEW CDC PUBLICATIONS

CDC. Human tuberculosis caused by Mycobacterium bovis—New York City, 2001–2004. MMWR 2005 June 24; 54 (24): 605-608.

CDC. Multidrug-resistant tuberculosis in Hmong refugees resettling from Thailand into the United States, 2004-2005. MMWR 2005 Aug 5; 54 (30): 741-4.

Driver CR, Matus SP, Bayuga S, Winters AI, and Munsiff SS. Factors associated with tuberculosis treatment interruption in New York City. Journal of Public Health Management and Practice 2005 July/August; 11(4): 361-8.

Frieden TR and Munsiff SS. The DOTS strategy for controlling the global tuberculosis epidemic. Clinics in Chest Medicine 2005 Jun; 26(2): 197-205.

Granich RM, Oh P, Lewis B, Porco TC, Flood J. Multidrug resistance among persons with tuberculosis in California, 1994-2003. JAMA 2005 Jun 8; 293(22): 2732-9.

Laserson KF, Yen NTN, Thornton CG, Mai VTC, Jones W, An DQ, Phuoc NH, Trinh NA, Nhung DTC, Lien TX, Lan NTN, Wells C, Binkin N, Cetron M, Maloney SA. Improved sensitivity of sputum smear microscopy after processing specimens with C18-carboxypropylbetaine to detect acid-fast bacilli: a study of United States–bound immigrants from Vietnam. Journal of Clinical Microbiology 2005 July; 43(7): 3460-3462.

Leimane V, Riekstina V, Holtz TH, Zarovska E, Skripconoka V, Thorpe LE, Laserson KF, Wells CD. Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study. The Lancet 2005; 365: 318-326.

Levy MZ, Medeiros EA, Shang N, Soares MC, Homenko AS, Almeida RM, Garrett DO, Roth VR, Jarvis WR, Wells CD, Binkin N, and Laserson KF. TST reversion in a BCG-revaccinated population of nursing and medical students, Sao Paulo, Brazil, 1997-2000. International Journal of Tuberculosis and Lung Disease 2005 Jul; 9 (7): 771-6.

Li J, Munsiff SS, Driver CR, and Sackoff J. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000. Clinical Infectious Diseases 2005 Jul 1; 41(1): 83-91.

Maus CE, Plikaytis BB, and Shinnick TM. Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy 2005 Aug; 49(8): 3192-3197.

Nelson LJ, Talbot EA, Mwasekaga MJ, Ngirubiu PK, Mwansa RA, Notha M, Wells CD. Antituberculosis drug resistance and anonymous HIV surveillance in tuberculosis patients in Botswana, 2002. The Lancet 2005; 366: 488-490.

Pai M, Gokhale K, Joshi R, Dogra S, Kalantri S, Mendiratta DK, Narang P, Daley CL, Granich RM, Mazurek GH, Reingold AL, Riley LW, Colford JM. Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA 2005 Jun 8; 293(22): 2746-55.

Skenders G, Fry AM, Prokopovica I, Greckoseja S, Broka L, Metchock B, Holtz TH, Wells CD, Leimane V. Multidrug-resistant tuberculosis detection, Latvia. Emerging Infectious Diseases 2005 Sept; 11(9): 1461-1463.

Tappero JW, Bradford WZ, Agerton TB, Hopewell P, Reingold AL, Lockman S, Oyewo A, Talbot EA, Kenyon TA, Moeti TL, Moffat HJ, and Peloquin CA. Serum concentrations of antimycobacterial drugs in patients with pulmonary tuberculosis in Botswana. Clinical Infectious Diseases  2005 Aug 15;41(4): 461-9.

Williams BG, Granich R, Chauhan LS, Dharmshaktu NS, Dye C. The impact of HIV/AIDS on the control of tuberculosis in India. Proceedings of the National Academy of Sciences of the United States of America 2005 July 5; 102 (27): 9619-24.

 


Released October 2008
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination - http://www.cdc.gov/tb

Please send comments/suggestions/requests to: hsttbwebteam@cdc.gov, or to
CDC/Division of Tuberculosis Elimination
Communications, Education, and Behavioral Studies Branch
1600 Clifton Rd., NE - Mailstop E-10, Atlanta, GA 30333